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Hepatotoxic effectAbstract Several-1-carbothioamide-3,5-dimethyl-4-[(substituted phenyl) diazenyl] pyrazoles 2a–d,
1-(pyridine-4-ylcarbonyl)-3,5-dimethyl-4-[(substituted phenyl) diazenyl] pyrazoles 3a–d,
1-(5-chloro-6-ﬂuoro-1,3-benzothiazole-2-yl)thiocarbamoyl-3,5-dimethyl-4-[(substituted phenyl)
diazenyl] pyrazoles 4a–d and 1-[(1,2,4-triazole-4-yl) carbothioamide]-3,5-dimethyl-4-[(substituted
phenyl) diazenyl] pyrazoles 5a–d were synthesized. The structures of the newly synthesized com-
pounds were supported by IR, 1H NMR and mass spectral data. These compounds were investi-
gated for their, anti-inﬂammatory, analgesic, ulcerogenic, lipid peroxidation, antibacterial and
antifungal activities. Some of the synthesized compounds showed potent anti-inﬂammatory activity
along with minimal ulcerogenic effect and lipid peroxidation, compared to ibuprofen and ﬂurbipro-
fen. Some of the tested compounds also showed moderate antimicrobial activity against tested bac-
terial and fungal strains.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Currently, available non-steroidal anti-inﬂammatory drugs
(NSAIDs) like, ibuprofen, ﬂurbiprofen, fenbufen and naproxen
exhibit gastric toxicity. Long-term use of these drugs has been
associated with gastro-intestinal (GI) ulceration, bleeding and
nephrotoxicity (Kimmey, 1992). The GI damage from NSAIDsis generally attributed to two factors, i.e. local irritation by the
carboxylic acid moiety, common to most NSAIDs (topical ef-
fect) and decreased tissue prostaglandin production, which
undermines the physiological role of cytoprotective prostaglan-
dins in maintaining GI health and homeostasis (Smith et al.,
1998; Hawkey et al., 2000). The pharmacological activity of
NSAIDs is related to the suppression of prostaglandin biosyn-
thesis from arachidonic acid by inhibiting cyclooxygenases
(COXs) (Smith et al., 1998; Warner et al., 1999). The chronic
use of NSAIDs including ibuprofen may elicit appreciable GI
toxicity (Lanza, 1998). Therefore synthetic approaches based
upon NSAIDs chemical modiﬁcation has been taken with the
aim of improving NSAID safety proﬁle. In view of the potential
biological activities (Ahuwalia and Mittal, 1989; Werbal and
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arylazo pyrazoles we report herein the synthesis of some new-1-
(substituted)-3,5-dimethyl-4-[(substituted phenyl) diazenyl]
pyrazoles. The synthesis involves treatment of acetyl acetone
with different diazonium salt in the presence of sodium acetate
when 3-[(substituted phenyl) diazenyl] pentane-2,
4-dione 1a–d are obtained. The later on treatment with
carbothioamide, pyridine-4-ylcarbonyl, 5-chloro-6-ﬂuoro-1,3-
benzothiazole-2-yl-thiocarbamoyl and 1,2,4-triazole-4-yl car-
bothioamide furnished 1-(substituted)-3,5-dimethyl-4-[(substi-
tuted phenyl) diazenyl] pyrazoles (Scheme 1). In view of the
reported antimicrobial activity of pyrazole, these compounds
were also tested for their antibacterial and antifungal activities
against some selected microbes. Two selected compounds were
also studied for their hepatotoxic effects on rat liver. The struc-NH2
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Schemetures of the various compounds were assigned on the basis of
IR, 1H NMR and mass spectral data.
2. Chemistry
Carbothioamide-3,5-dimethyl-4-[(substituted phenyl) diazenyl]
pyrazoles (2a–d), 1-(pyridine-4-ylcarbonyl)-3,5-dimethyl-4-
[(substituted phenyl) diazenyl] pyrazoles (3a–d), 1-(5-chloro-6-
ﬂuoro-1,3-benzothiazole-2-yl) thiocarbamoyl-3,5-dimethyl-4-
[(substituted phenyl) diazenyl] pyrazoles (4a–d) and 1-[(1,2,
4-triazole-4-yl) carbothioamide]-3,5-dimethyl-4-[(substituted
phenyl) diazenyl] pyrazoles (5a–d) were obtained by cyclization
of intermediates 1a–d with thiosemicarbazide, isonicotinic acid
hydrazide, 5-chloro-6-ﬂuoro-1,3-benzothiazole-2-yl-thiosemi-
carbazide and N-4H-1,2,4-triazol-4-ylhydrazine. The interme-N N CH
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Table 1 Anti-inﬂammatory and antimicrobial activity of the compounds (2a–d & 3a–d, 4a–d & 5a–d).
Compound R Anti-inﬂammatory activity# Antimicrobial activity
Diﬀerence in paw volume % Inhibition ± SEM MIC##
After 4 h S. aureus E. coli C. albicans
2a m-Cl, p-F 0.08 ± 0.008 80.29 ± 1.51 200 200 200
2b p-SO2NH2 0.27 ± 0.013 38.63 ± 3.05
d 200 25 100
2c
N
N
SO2NH
CH3
CH3
P
0.18 ± 0.008 57.57 ± 1.91d 200 100 12.5
2d m-COOH, p-OH 0.09 ± 0.008 78.78 ± 1.91 200 12.5 200
3a m-Cl, p-F 0.36 ± 0.018 18.17 ± 4.23d 50 200 200
3b p-SO2NH2 0.15 ± 0.013 65.14 ± 3.03
c 25 25 - -
3c
N
N
SO2NH
CH3
CH3
P
0.09 ± 0.013 78.78 ± 3.03 100 25 50
3d m-COOH, p-OH 0.21 ± 0.012 50.75 ± 2.73d 25 50 50
4a m-Cl, p-F 0.23 ± 0.011 47.72 ± 2.56d 25 50 25
4b p-SO2NH2 0.10 ± 0.014 76.51 ± 3.65 50 200 200
4c
N
N
SO2NH
CH3
CH3
P
0.08 ± 0.009 80.29 ± 2.25 200 100 50
4d m-COOH, p-OH 0.14 ± 0.012 68.17 ± 3.10c 100 25 - -
5a m-Cl, p-F 0.31 ± 0.009 28.02 ± 2.17d 200 200 200
5b p-SO2NH2 0.20 ± 0.011 53.02 ± 2.54
d 200 50 200
5c
N
N
SO2NH
CH3
CH3
P
0.15 ± 0.013 65.90 ± 3.05c - - 100 25
5d m-COOH, p-OH X X X X - - 25 200
Ibuprofen 0.08 ± 0.012 80.38 ± 2.62 X X X X X X
Flurbiprophen 0.08 ± 0.009 80.29 ± 2.25 X X X X X X
Ketoconazole X X X X X X X X 6.25
Oﬂoxacin X X X X 6.25 6.25 - -
Control 0.44 ± 0.016 - - - - - -
- - Did not show any activity.X X Not tested.
# Relative to their respective standard and data were analyzed by ANOVA followed by Dunnett’s multiple comparison test for n= 6.
c p< 0.05.
d p< 0.01.
## lg ml1.
276 S. Hussain, D. Kaushikdiates 1a–d were obtained via coupling acetylacetone with diaz-
otized aromatic amines. The reaction sequences are outlined in
Scheme 1.
3. Result and discussion
3.1. Spectral characterization of the compounds
The IR spectrum of the compounds (1a–d) showed peaks at
2993–3012 cm1, CH stretching; 1661–1693 cm1, C‚O
stretching and 1536–1573 cm1, –N‚N– stretching vibrations.
The NMR spectrum of the compound 1a showed a singlet at d
1.78 indicating the presence of N–CH proton. The signals of
two COCH3 were obtained as singlets at d 2.35 and d 2.43. In
the aromatic region multiplets were obtained at d 7.37–7.51indicating the presence of three aromatic protons. The NMR
spectrum of the compound 1d showed a singlet at d 1.65 indi-
cating the presence of N–CH proton. The protons of two
COCH3 were obtained as singlets at d 2.47 and d 2.59. Further-
more multiplets were obtained at 6.93–7.35 indicating the pres-
ence of three aromatic protons. The COOH proton was
obtained as a singlet at d 10.2. The IR spectrum of the com-
pounds (2a–d) showed peaks at 2958–3018 cm1, CH stretch-
ing, 1574–1613 cm1, –N‚N– stretching and 1038–1080 cm
1, C‚S stretching vibrations. The NMR spectrum of the com-
pound 2a showed a singlet observed at d 2.17, indicating the
presence of methyl groups attached to the 3rd position of the
pyrazole ring. A singlet was observed at d 4.14 due to two pro-
tons of S‚C–NH2. In the aromatic region a multiplet of three
protons was observed at d 7.12–7.38. The IR spectrum of the
Table 2 Analgesic, ulcerogenic and lipid peroxidation activity of selected compounds.
Compound Analgesic activity# Ulcerogenic activity##
(Severity index ± SEM)
nmol MDA
content ± SEM/100 mg
tissue##
Pre-treatment/normal 0 h (s) Post-treatment/after 4 h (s) % Inhibition
2a 1.810 ± 0.186 2.467 ± 0.290 36.2 0.333 ± 0.10 d 5.04 ± 0.53d
2d 0.992 ± 0.076 1.362 ± 0.139 37.3c 0.75 ± 0.25 d 5.65 ± 0.36e
3b 1.156 ± 0.067 1.706 ± 0.069 48.1a 0.833 ± 0.24e 5.82 ± 0.50e
4c 1.482 ± 0.153 2.200 ± 0.162 48.4a 0.417 ± 0.08 d 4.82 ± 0.25d
5a 1.217 ± 0.120 1.843 ± 0.147 51.4b 1.000 ± 0.31d 5.78 ± 0.97e
5b 1.171 ± 0.084 1.620 ± 0.088 38.3c 0.667 ± 0.10d 5.12 ± 0.29
5d 1.860 ± 0.223 2.513 ± 0.202 53.1b 0.666 ± 0.16d 5.62 ± 0.29e
Control - - - - - - 0.00 3.25 ± 0.05
Ibuprofen 1.361 ± 0.086 2.37 ± 0.131 74.1a 2.000 ± 0.13 7.79 ± 0.13
Flurbiprofen 1.15 ± 0.060 1.95 ± 0.097 69.5a 1.666 ± 0.24 7.51 ± 0.68
# Relative to normal and data were analyzed by paired Student’s t test for n= 6.
a p< 0.0001.
b p< 0.001.
c p< 0.01.
## Relative to their respective standard and data were analyzed by ANOVA followed by Dunnett’s multiple comparison test for n= 6.
d p< 0.01.
e p< 0.05.
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stretching, 1577–1614 cm1, –N‚N– stretching and 1630–
1666 cm1, C‚O stretching vibrations. The NMR spectrum
of the compound 3b showed a merged singlet of methyl protons
attached to the 3rd and 5th positions of the pyrazole ring at d
2.46. In the aromatic region a multiplet was obtained at d
7.85–7.88 indicating the presence of four pyridyl protons. In
the aromatic region a multiplet was obtained at d 7.10–7.70
indicating the presence of four aromatic protons. The NMR
spectrum of the compound 3d showed a singlet of COOH pro-
tons at d 10.4. In the aromatic region two multiplets were ob-
tained at d 6.96–7.43 and 7.45–7.82 indicating the presence of
three aromatic protons and four pyridyl protons respectively.
The IR spectrum of the compounds (4a–d) showed peaks at
2979–3018 cm1, CH stretching, 1530–1560 cm1, –N‚N–
stretching and 1564–1616 cm1, C‚C stretching of aromatic
ring. The NMR spectrum of the compound 4a showed two
singlets at d 2.61 and d 3.18 indicating the presence of methyl
protons attached at 3rd and 5th positions of the pyrazole ring.
In the aromatic region a complex multiplet was obtained at d
7.12–7.48 indicating the presence of 5 aromatic protons. The
IR spectrum of the compounds (5a–d) showed peaks at 2981–
3013 cm1, CH stretching; 1508–1567 cm1, –N‚N– stretch-
ing and 1050–1086 cm1, C‚S stretching. The NMR spectrum
of the compound 5d showed two singlets at d 2.72 and d 3.28
indicating the presence of methyl protons attached to the 3rd
and 5th positions of the pyrazole ring. A multiplet of 3 protonsTable 3 Effect of compounds on serum enzymes, total proteins an
Compound SGOT# (Units/ml) SGPT# (Units/ml) Alkalin
Control 148.67 ± 1.50 27.67 ± 0.84 13.06 ±
2a 147.50 ± 0.34 28.17 ± 0.83 15.18 ±
4c 137.00 ± 0.72a 26.50 ± 0.72 17.07 ±
# Relative to control and data were analyzed by Students’s t test for n
a p< 0.0001.
b p< 0.01.was observed in the aromatic region at d 7.22–7.54. Further-
more, a singlet for S‚C–NH proton was also observed at d
4.16.
3.2. Pharmacological results and discussion
The anti-inﬂammatory activity of the synthesized compounds
2a-d, 3a-d and 4a–d was evaluated by carrageenan induce paw
edema method of Winter et al. (1962). The compounds (2a-d,
3a-d) were tested at an equimolar oral dose relative to
70 mg/kg ibuprofen and the compounds (4a-d, 5a-c) were
tested at an equimolar oral dose relative to 10 mg/kg ﬂurbipro-
fen. The tested compounds showed anti-inﬂammatory activity
ranging from 18.17% to 80.29%, whereas standard drug ibu-
profen and ﬂurbiprofen showed 80.38 and 80.29% inhibition
respectively after 4 h (Table 1). The anti-inﬂammatory activity
of pyrazole derivatives is in the range of 18.17–80.29%. It was
observed that the pyrazole derivatives 2a (80.29%) and 4c
(80.29%) have shown the activity almost equal to standard
drug, ibuprofen (80.38%). Compounds 2d, 3c and 4b showed
moderate activity. Test compounds that exhibited potent
anti-inﬂammatory activity 2a, 2d, 3c, 4b, and 4c were further
evaluated for their analgesic and ulcerogenic activities. All
the compounds showed moderate analgesic activity in compar-
ison to their standard drugs. The tested compounds showed
signiﬁcant reduction in ulcerogenic activity ranging from
0.333 ± 0.10 to 1.000 ± 0.31, whereas the standard drug ibu-d total albumin.
e phophatase# Total protein# (g/dl) Total albumin# (g/dl)
0.25 1.80 ± 0.01 1.67 ± 0.01
0.13a 1.89 ± 0.07 1.80 ± 0.05b
0.11a 0.90 ± 0.09a 0.71 ± 0.07a
= 6.
278 S. Hussain, D. Kaushikprofen and ﬂurbiprofen showed high severity index of
2.000 ± 0.13 and 1.666 ± 0.24 respectively. In general, the
tested compounds showed a better GI safety proﬁle compared
to standard drugs (Table 2).
It has been reported in the literature that compounds show-
ing less ulcerogenic activity also showed reduced malondialde-
hyde (MDA) content, a byproduct of lipid peroxidation
(Naito et al., 1998; Pohle et al., 2001). Therefore, an attempt
was made to correlate the decrease in ulcerogenic activity of
the compounds with that of lipid peroxidation. All the com-
pounds screened for ulcerogenic activity were also analyzed
for lipid peroxidation. The lipid peroxidation was measured
as n mole of MDA/100 mg of tissue. The ibuprofen and ﬂurbi-
profen exhibited maximum lipid peroxidation 7.79 ± 0.13 and
7.51 ± 0.68 respectively, whereas control group showed
3.25 ± 0.05. It was found that all the cyclized derivatives show-
ing less ulcerogenic activity also showed reduction in lipid per-
oxidation (Table 2). Thus these studies showed that synthesized
compounds have inhibited the induction of gastric mucosal
lesions and the results further suggested that their protective ef-
fect might be related to the inhibition of lipid peroxidation in
gastric mucosa.
The compounds 2a and 4c, derivatives of pyrazole showing
potent anti-inﬂammatory activity with reduced ulcerogenicity
and lipid peroxidation were further studied for their hepato-
toxic effect. Both the compounds were studied for their effect
on biochemical parameters (serum enzymes, total protein and
total albumin) and histopathology of liver. As shown in Table
3, activities of liver enzymes SGOT, SGPT, alkaline phospha-
tase and total protein, total albumin almost remain same with
respect to control values, except for compound 4c in which to-
tal protein and total albumin were markedly reduced. The his-
topathological studies of the liver samples do not show any
signiﬁcant pathological changes in comparison to control
group. No hepatocyte necrosis or degeneration was seen in
any of the samples.
Compounds (2a–d,3a–d, 4a–d and 5a–d) have been evaluated
for their in vitro anti-microbial activity against Staphylococcus
aureus (ATCC-29737), as an example of gram-positive bacteria,
Escherichia coli (ATCC-8739) as an example of gram-negative
bacteria and Aspergilus niger as a representative of fungi using
cup plate technique. DMF (N,N-dimethyl formamide) was run
as a control and test was performed at 200, 100, 50, 25 lg/ml
concentration. Oﬂoxacin and ketoconazole were used as stan-
dard drugs. The micro dilution susceptibility test in nutrient
agar media (Hi-Media), Sabroaud’s dextrose agar media were
used for the determination of antibacterial and antifungal activ-
ities respectively. The minimal inhibitory concentration (MICs,
lg mL1) of the tested compounds were recorded in Table 1.
The results revealed that most of the newly synthesized pyrazole
derivatives bearing isonicotinic acid hydrazide moiety (3a–d)
exhibited promising anti-bacterial activity. Out of the tested
compound, compound 3a and 5a having 3-chloro, 4-ﬂuoro
groups in the phenyl ring exhibited remarkable antibacterial
activity against E. coli (gram negative bacteria), S. aureus (gram
positive bacteria) andA. niger fungi whereas compound 3d hav-
ing COOH, OH group at meta and para positions of the phenyl
ring showedMIC 50 lg mL1 against S. aureus, E. coli, as com-
pared with the broad spectrum antibiotics Oﬂoxacin (MIC
10.0 lg mL1 against S. aureus and 12.5 lg mL1 against E.
coli).The antifungal screening results have shown that the com-
pounds 2a, 3a, 3c, 3d, and 4a exhibited good activity (MIC 25lg mL1) against A. niger, as compared with the standard drug
ketoconazole (MIC 12.5 lg mL1).
4. Pharmacology
4.1. Anti-inﬂammatory activity
The synthesized compounds were evaluated for their anti-
inﬂammatory activity using carrageenan induced hind paw
edema method of Winter et al. (1962). The experiment was per-
formed on Albino rats of Wistar strain of either sex, weighing
180–200 gm. The animals were randomly allocated into groups
of six animals each. One group was kept as control, received
only 0.5% carboxymethyl cellulose solution. Group II and
Group III were kept as standards and receive ibuprofen
(70 mg/kg p.o.) and ﬂurbiprofen (10 mg/kg p.o.), respectively.
Carrageenan solution (0.1% in sterile 0.9% NaCl solution) in
a volume of 0.1 mL was injected subcutaneously into the sub
plantar region of the right hind paw of each rat, 1 h after the
administration of the test compounds and standard drugs.
The right hind paw volume was measured before and after
4 h of carrageenan treatment by means of a plethysmometer.
The percent anti-inﬂammatory activity was calculated accord-
ing to the following formula.
Percent anti-inflammatory activity ¼ Vc  Vt
Vc
 
 100
where Vt represents the mean increase in paw volume in rats
treated with test compounds and Vc represents the mean in-
crease in paw volume in the control group of rats.
4.2. Analgesic activity
Analgesic activity was evaluated by tail immersion method
(Janssen et al., 1963). Swiss albino mice allocated into different
groups consisting of six animals in each, of either sex, weighing
25–30 gm were used for the experiment. Analgesic activity was
evaluated after oral administration of the test compounds (2a–
d and 3a–d) at an equimolar dose relative to 70 mg/kg ibupro-
fen and test compounds (4a–d and 5a–c) at an equimolar dose
relative to 10 mg/kg ﬂurbiprofen. Test compounds and stan-
dard drugs were administered orally as suspension in carboxy-
methyl cellulose solution in water (0.5% w/v). The analgesic
activity was assessed before and after 4 h interval of the admin-
istration of test compounds and standard drugs. The lower
5 cm portion of the tail was gently immersed into thermostat-
ically controlled water at 55 ± 0.5 C. The time in second for
tail withdrawal from the water was taken as the reaction time
with a cut of time of immersion, set at 10 s for both control as
well as treated groups of animals.
4.3. Acute ulcerogenicity
Acute ulcerogenicity was determined according to Cioli et al.
(1979). The animals were allocated into different groups con-
sisting of six animals in each group. Ulcerogenic activity was
evaluated after oral administration of the test compounds
(2a and2d) at an equimolar dose relative to 210 mg/kg ibupro-
fen and test compounds (3c, 4b and 4c) at an equimolar dose
relative to 30 mg/kg ﬂurbiprofen. Control group received only
0.5% carboxymethylcellulose solution. Food but not water
was removed 24 h before administration of the test
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normal diet for 17 h and then sacriﬁced. The stomach was re-
moved and opens along the greater curvature, washed with dis-
tilled water and cleaned gently by dipping in normal saline.
The mucosal damage was examined by means of a magnifying
glass. For each stomach the mucosal damage was assessed
according to the following scoring system: 0.5: redness, 1.0:
spot ulcers, 1.5: hemorrhagic streaks, 2.0: ulcers >3 but 65,
3.0: ulcers >5. The mean score of each treated group minus
the mean score of control group was regarded as severity index
of gastric mucosal damage.
4.4. Lipid peroxidation
Lipid peroxidation in the gastric mucosa was determined
according to the method of Ohkawa et al. (1979). After screen-
ing for ulcerogenic activity, the gastric mucosa was scraped
with two glass slides, weighed (100 mg) and homogenized in
1.8 mL of 1.15% ice cold KCl solution. The homogenate
was supplemented with 0.2 mL of 8.1% sodium dodecyl sulfate
(SDS), 1.5 mL of acetate buffer (pH 3.5) and 1.5 mL of 0.8%
thiobarbituric acid (TBA). The mixture was heated at 95 C
for 60 min. After cooling the reactants were supplemented with
0.2 mL of 8.1% sodium dodecyl sulfate (SDS), 1.5 mL of ace-
tate buffer (pH 3.5) and 1.5 mL of 0.8% thiobarbituric acid
(TBA). The mixture was heated at 95 C for 60 min. After
cooling the reactants were supplemented with 5 ml of the mix-
ture of n-butanol and pyridine (15:1 v/v), shaken vigorously
for 1 min and centrifuged for 10 min at 4000 rpm. The super-
natant organic layer was taken out and absorbance was mea-
sured at 532 nm on UV spectrophotometer. The results were
expressed as nmol MDA/100 mg tissue, using extinction coef-
ﬁcient 1.56 · 105 cm1 M1.
4.5. Hepatotoxic studies
The study was carried out on Wistar albino rats of either sex
weighing 150–200 gm. Animals were divided into three groups,
six rats in each. Group 1 was kept as control and receives only
vehicle (0.5% w/v solution of carboxymethylcellulose in water),
groups 2 and 3 received compound 2a and 4c, respectively, in
0.5% w/v solution of carboxymethylcellulose in water for
15 days. After the treatment (15 days) blood was obtained from
all the groups of rats by puncturing the retro-orbital plexus.
Blood samples were allowed to clot for 45 min at room temper-
ature and serum was separated by centrifugation at 2500 rpm
for 15 min and analyzed for various biochemical parameters.
4.6. Assessment of liver function
Assessment of liver function such as serum glutamate oxaloac-
etate transaminase (SGOT) and serum glutamate pyruvate
transaminase (SGPT) was estimated by a reported method
(Reitman and Frankel, 1957). The alkaline phosphatase, total
protein and total albumin were measured according to the re-
ported procedures (King and Armstrong, 1934; Reinhold,
1953; Varley, 1988). All the data are recorded in Table 3.
4.7. Histopathological studies of liver
The histopathological studies were carried out by the reported
method (Luna, 1968). The rats were sacriﬁced under light etheranesthesia after 24 h of the last dosage, the liver was removed
and washed with normal saline and stored in formalin solu-
tion. Section of 5–6 lm in thickness was cut, stained with
hematoxylin and eosin and then studied under an electron
microscope.
4.8. Antibacterial and antifungal activities
Antibacterial activity of the synthesized compounds was deter-
mined in vitro by using dish diffusion method (Barry, 1976)
against S. aureus (gram-positive), E. coli (gram negative) at
25, 50, 100 and 200 lg ml1 concentration respectively, in
the nutrient agar media by measuring the zone of inhibition
in mm. Standard antibiotic Oﬂoxacin was used as reference
drug at 25 and 50 lg ml1 concentrations.
Similarly, the antifungal activity of the synthesized com-
pounds was determined in vitro by dish diffusion method
against fungal strain A. niger at 25, 50, 100 and 200 lg ml1
concentrations in sudroad dextrose medium by using ketocon-
azole as standard drug at 25 and 50 lg ml1 concentrations.
The zone of inhibition was measured in mm. The compounds
which showed inhibition at 25 lg ml1 concentration were fur-
ther tested at 12.5 and 6.25 lg ml1 concentrations. DMF was
used as solvent to prepare the desired concentration of the syn-
thesized compounds.5. Conclusion
In summary, we have described the synthesis and pharmaco-
logical activity of 1-(substituted)-3,5-dimethyl-4-[(substituted
phenyl) diazenyl] pyrazoles derivatives. It was observed that
the pyrazole derivatives 2a and 4c have shown the activity al-
most equal to the standard drug, ibuprofen and some of the
compounds showed moderate analgesic activity in comparison
to their standard drugs. The compounds 2a and 4c were fur-
ther studied for their hepatotoxic effect. Both the compounds
were studied for their effect on biochemical parameters and
histopathology of liver. The histopathological studies of the li-
ver samples did not show any signiﬁcant pathological changes
in comparison to the control group. All compounds were also
tested for their antimicrobial activity.6. Experimental protocols
Melting points were determined in open capillary tubes. IR
spectra were recorded on a Perkin-Elmer 157 spectrometer
and 1H NMR spectra on a Bucker WM-400 (400 MHz FT
NMR) spectrophotometer using TMS (Tetramethyl Silane)
as internal reference (chemical shift in d ppm). Purity of the
compounds was checked by TLC (Thin Layer Chromatogra-
phy) on silica gel plates and spots were visualized by the expo-
sure to iodine vapors. The physical data of the compounds
prepared are presented in Table 1.
6.1. 3-[(Substituted phenyl) diazenyl] pentane-2,4-dione (1a–
d)
Substituted aniline (0.05 mol) was dissolved in dil. HCl (40 ml,
1:1). The contents were stirred and cooled (0–2 C) and a cold
solution of sodium nitrite (6.0 g in 15 ml of water) was added
to it slowly maintaining the temperature between 0 C and
280 S. Hussain, D. Kaushik2 C. The cold diazotized solution was added drop wise to a
well cooled and stirred mixture of acetyl acetone (0.05 mol)
and sodium acetate (4 g, dissolved in 5 ml of 50% ethanol).
The stirring was continued for 1.5 h and crystals separated
were ﬁltered, washed with water, dried and crystallized from
ethanol to yield (1a–d). IR (KBr) 1a–d: 2993–3012 cm1, CH
stretching, 1661–1693 cm1, C‚O stretching and 1536–
1573 cm1, N‚N stretching vibration; 1H NMR (CDCl3) 1a:
d 1.78 (s, 1H, N–CH). The signals of two COCH3 were ob-
tained as singlets at d 2.35 and d 2.43, d 7.37–7.51 (m, 3H,
Ar-H); 1d: d 1.65 (s, 1H, N–CH). The signals of two COCH3
were obtained as singlets at d 2.47 and d 2.59, d 6.93–7.35
(m, 3H, Ar-H) and d 10.2 (s, 1H, COOH).
6.2. 1-Carbothioamide-3,5-dimethyl-4-[(substituted phenyl)
diazenyl] pyrazoles (2a–d)
3-[(Substituted phenyl) diazenyl] pentane-2, 4-dione (1a–d,
0.001 mol) and thiosemicarbazide (0.001 mol) were dissolved
in glacial acetic acid (10 ml) and the solution was reﬂuxed
for 20 h. The resulting solid was puriﬁed by repeated washing
with acetic acid and crystallization from acetic acid to get 2a–
d. IR (KBr) 2a-d: 1038–1080 cm1 (C‚S), 1574–1613 cm1
(N‚N) and at 2958–3018 cm1 (CH stretching); 1H NMR
(CDCl3) 2a: d 2.17 (s, 3H of CH3 attached to the 3rd position
of the pyrazole ring), d 4.14 (s, 2H, S‚C–NH2), d 7.38–8.12
(m, 3H, Ar-H).
6.3. 1-(Pyridine-4-ylcarbonyl)-3,5-dimethyl-4-[(substituted
phenyl) diazenyl] pyrazoles (3a–d)
3-[(Substituted phenyl) diazenyl] pentane-2,4-dione (1a–d,
0.001 mol) and 2 isonicotinic acid hydrazide (0.001 mol) were
dissolved in glacial acetic acid (10 ml) and the solution was re-
ﬂuxed for 20 h. The resulting solid was ﬁltered, washed with
acetic acid and recrystallized from acetic acid to obtain 3a–d.
IR (KBr) 3a–d: 1577–1614 cm1 (N‚N) and 1630–1666
(C‚O), 2980–3013 (CH stretching); 1H NMR (CDCl3) 3b:
merged singlet observed at d 2.46, indicating the presence of
3 and 5 methyl groups attached to pyrazole ring. d 7.85–7.88
(m, 4H, pyridyl) and d 7.10–7.70 (m, 4H, Ar-H); 3d: d 6.96–
7.43 (m, 3H, Ar-H), d 7.44–7.82 (m, 4H, pyridyl) and 10.4 (s,
1H,COOH).6.4. 1-(5-Chloro-6-ﬂuoro-1,3-benzothiazole-2-yl)
thiocarbamoyl-3,5-dimethyl-4-[(substituted phenyl) diazenyl]
pyrazoles (4a–d)
3-[(Substituted phenyl) diazenyl] pentane-2,4-dione (1a–d,
0.001 mol) and 5-chloro-6-ﬂuoro-1,3-benzothiazole-2-yl-thio-
semicarbazide (0.001 mol) were dissolved in glacial acetic acid
(10 ml) and the solution was reﬂuxed for 20 h. The resulting
solid was ﬁltered, washed with acetic acid and recrystallized
from acetic acid to obtain 4a–d. IR (KBr) 4a–d: 2979–
3018 cm1 (CH stretching), 1530–1560 cm1 (N‚N stretch-
ing), 1564–1616 cm1 (C‚C stretching of aromatic ring);
1H NMR (CDCl3) 4a: two singlets at d 2.61 and d 3.18 indi-
cating the presence of methyl protons attached at 3rd and 5th
positions of the pyrazole ring. d 7.12–7.48 (complex m, 5H,
Ar-H).6.5. 1-[(1,2,4-Triazole-4-yl) carbothioamide]-3,5-dimethyl-4-
[(substituted phenyl) diazenyl] pyrazoles (5a–d)
3-[(Substituted phenyl) diazenyl] pentane-2,4-dione (1a–d,
0.001 mol) and N-4H-1,2,4-triazol-4-ylhydrazine (0.001 mol)
were dissolved in glacial acetic acid (10 ml) and the solution
was reﬂuxed for 20 h. The reaction mixture was cooled and
the compound separated was ﬁltered, washed with acetic acid.
It was further puriﬁed by recrystallization from acetic acid to
get (5a–d). IR (KBr) 5a–d: 1050–1086 cm1 (C‚S), 1508–
1567 cm1 (N‚N) and 2981–3013 cm1 (CH stretching); 1H
NMR (CDCl3) 5d: d 4.16 (s, 1H, S‚C–NH), two singlet at
d 2.72 and d 3.28 indicating the presence of methyl protons at-
tached at 3rd and 5th positions of the pyrazole ring and d 7.22–
7.54 (m, 3H, Ar-H).Acknowledgements
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